Search
Septerna Inc
SEPNAdd to Watchlist
44.561USD
+0.061+0.14%
Market hours （ET）Quotes delayed by 15 min
2.03BMarket Cap
LossP/E TTM
Forecast
Currency: USD Updated: 2026-08-14The current earnings forecast score of Septerna Inc is 8.60, ranking 98 out of 387 in the Biotechnology & Medical Research industry. The average price target is 29.00, with a high of 34.00 and a low of 25.00.
Analyst Rating
Based on
10
analysts
Buy
Current Rating
55.000
Target Price
+23.60%
Upside Space
Strong Buy
Buy
Hold
Sell
Strong Sell
Peer Comparison
497
Total
6
Median
7
Average
Company name
Ratings
Analysts
Septerna Inc
SEPN
10
argenx SE
ARGX
28
Beigene Ltd
ONC
28
Ionis Pharmaceuticals Inc
IONS
25
IQVIA Holdings Inc
IQV
24
Kymera Therapeutics Inc
KYMR
23
1
2
3
...
100
Support & Resistance
Relevant data have not been disclosed by the company yet.
Financial Forecasting
EPS
Revenue
Net Profit
EBIT
Forecast
Actual
FAQs
What is Septerna Inc's expected revenue for the next quarter?
Septerna Inc's expected revenue is 19.85M.
What is Septerna Inc's price target?
Analysts forecast that Septerna Inc's price target is USD 29.00, with the highest forecast at USD 34.00 and the lowest forecast at USD 25.00.
How have Septerna IncSEPN's recent earnings per share performed?
The market expectation was USD -0.29, while Septerna IncSEPN's earnings per share (EPS) for the previous quarter was USD -0.19. EPS for the next quarter is expected at USD -0.47.
What is the analyst rating for Septerna Inc?
Based on the ratings of Septerna Inc's stock from 10 analysts, most analysts support a Buy trend. After considering the opinions of other analysts, we ultimately rate Apple's stock as Buy. Please note that this is not trading advice. You still need to conduct your own analysis.